Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Lacosamide

Lacosamide

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Lacosamide

37 trials tracked of Lacosamide: 24 in phase 3 or 4.

37Trials tracked
24Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 3 Phase 3 21 Phase 2 9 Phase 1 1 Other / NA 3
  1. Phase 4 Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure Completed
  2. Phase 4 Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy Completed
  3. Phase 4 Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures Completed
  4. Phase 3 A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures Completed
  5. Phase 3 A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy Completed
  6. Phase 3 A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment Completed
Show 31 more trials
  1. Phase 3 Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures Completed
  2. Phase 3 Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older Completed
  3. Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures Completed
  4. Phase 3 Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older Completed
  5. Phase 3 Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures Completed
  6. Phase 3 Add on Lacosamide Versus High Dose Monotherapy Completed
  7. Phase 3 Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures Completed
  8. Phase 3 Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures Completed
  9. Phase 3 Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children. Completed
  10. Phase 3 A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures Completed
  11. Phase 3 Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures Completed
  12. Phase 3 Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures Completed
  13. Phase 3 A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy Completed
  14. Phase 3 Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures Completed
  15. Phase 3 A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994 Completed
  16. Phase 3 Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures Completed
  17. Phase 3 Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy. Completed
  18. Phase 3 eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam Completed
  19. Phase 2 An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain Completed
  20. Phase 2 A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis Completed
  21. Phase 2 A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. Completed
  22. Phase 2 Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome. Completed
  23. Phase 2 Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy Completed
  24. Phase 2 Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy Completed
  25. Phase 2 To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures Completed
  26. Phase 2 An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy Completed
  27. Phase 2 A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures Completed
  28. Phase 1 Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers Completed
  29. N/A Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older Completed
  30. N/A Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy Completed
  31. N/A Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures Completed

Showing the 37 most-cited and recently-updated of 37 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.